Open Access News

News from the open access movement


Wednesday, March 18, 2009

New OA journal on pathogens

Gut Pathogens is a new peer-reviewed OA journal published by the International Society for Genomic and Evolutionary Microbiology and BioMed Central. The article-processing charge is £850/US$1190/€920, subject to discounts or waiver. Authors retain copyright and articles are published under the Creative Commons Attribution License. See the inaugural editorial, published February 3, 2009:

As the open access movement begins revolutionizing the publication of publicly funded biomedical research, it is time to ensure access to important scientific discoveries and opinions within and across the disciplines which have direct bearing on health and quality of life in resource poor settings and in countries of the world where library budgets are seriously shrinking. In this concern, the area of enteric infectious diseases and gut health has been of paramount significance. For example, the enteric infections that cause diarrhoeal diseases already constitute one of the top 10 causes of death and kill approximately 1.81 million people in the developing world (6.9% of total deaths), a figure which is more dramatic and alarming than the number of deaths associated with tuberculosis and malaria put together.

To this end, the International Society for Genomic and Evolutionary Microbiology (ISOGEM) in collaboration with BioMed Central Ltd. has launched Gut Pathogens with the aim of providing a high-quality forum for research on enteric infections of humans and animals. The journal led by three Editors-in-Chief and supported by a highly qualified and organized international Editorial Board publishes open access research articles of repute in areas of biology and the pathogenesis of bacterial, parasitic and viral infections of the gut including their diagnosis, epidemiology and clinical management. ...

As like all BioMed Central journals, Gut Pathogens shall be committed to the open access publication policy – the concept that has revolutionized research access to communities and that was recently endorsed by major funding agencies including the NIH and the Wellcome Trust. ...